G. Michael Felker, MD

G. Michael Felker, MD

G. Michael Felker, MD

Therapeutic Area Lead, Cardiovascular Research, DCRI

Professor of Medicine, Division of Cardiology
Vice-Chief of Cardiology for Clinical Research

G. Michael Felker, MD, MHS, FACC, FAHA, FHFSA, is Professor of Medicine with tenure in the Division of Cardiology at Duke University School of Medicine. He is currently Director of Cardiovascular and Metabolism Therapeutic Area at the Duke Clinical Research Institute. He was formerly Chief of the Heart Failure Section at Duke University School of Medicine from 2013 to 2020.  He graduated from Duke University School of Medicine, completed his internal medicine training at Johns Hopkins Hospital where he was chief resident, and his training in Cardiology and Heart Failure at Duke. He is Board Certified in Advanced Heart Failure and Transplant Cardiology, and his clinical focus is on the care of patients with acute and chronic heart failure as well as patients with heart transplants and mechanical cardiac support.

Dr. Felker has published over 500 peer-reviewed articles and book chapters in the field of heart failure. He has served on the Executive and Steering Committees for multiple national and international clinical trials in heart failure. Dr. Felker is an editorial board member or peer reviewer for multiple high-impact medical journals, including the New England Journal of Medicine, JAMA, The Lancet, Circulation, and JACC. He is co-editor of Heart Failure: A Companion to Braunwald’s Heart Disease, the leading heart failure textbook. He is the immediate past-President of the Heart Failure Society of America (HFSA) and a member of the HFSA Board of Directors. His research focuses on clinical trials in acute and chronic heart failure and on the use of biomarkers as diagnostic, prognostic, and therapeutic tools in heart failure.